View on Pubmed.gov 11589691 | View on doi.org 10.1046/j.0014-...
The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.
- MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 4HN, Scotland, UK. p.cohen@dundee.ac.uk
Abstract
The reversible phosphorylation of proteins regulates almost all aspects of cell life, while abnormal phosphorylation is a cause or consequence of many diseases. Mutations in particular protein kinases and phosphatases gives rise to a number of disorders and many naturally occurring toxins and pathogens exert their effects by altering the phosphorylation states of intracellular proteins. In this lecture, I present an overview of the progress that is being made in developing specific inhibitors of protein kinases for the treatment of cancer and chronic inflammatory diseases and describe how recent advances in our understanding of the specificity and regulation of one particular protein kinase (GSK3) may facilitate the development of drugs to treat diabetes that would not have the potential to be oncogenic. I also discuss the exploitation of specific protein kinase inhibitors for the study of cell signalling and make recommendations for their effective use in cell-based assays.
References
Cited by 655 citations (total)
Journal Article
The geometry of multisite phosphorylation.
Electronic publication date January 22, 2009
Arjun Kumar Manrai [...] Jeremy Gunawardena et al.
Reversible protein phosphorylation on multiple sites is a key regulatory mechanism in most cellular processes. We consider here a kinase-phosphatase-substrate...
Journal Article Research Support, Non-U.S. Gov't
Systematic analysis of human kinase genes: a large number of genes and alternative splicing events result in functional and structural diversity.
Electronic publication date January 27, 2006
Luciano Milanesi [...] Giovanni Paolella et al.
BACKGROUND
Protein kinases are a well defined family of proteins, characterized by the presence of a common kinase catalytic domain and...
Conflict of interest statement
MeSH
- •
Specialties
Substances
- •
- •
- •
- •
- •